Development of antiinfliximab antibodies
โ
Gerrit Jan Wolbink; Marijn Vis; Willem Lems; Alexandre E. Voskuyl; Els De Groot;
๐
Article
๐
2006
๐
John Wiley and Sons
๐
English
โ 80 KB
๐ 2 views
## Abstract ## Objective Treatment of patients with infliximab, a chimeric monoclonal IgG1 antibody against tumor necrosis factor, may result in the formation of infliximabโspecific IgG antibodies. This study evaluated the clinical significance of these antibodies in patients with rheumatoid arthr